Анализ акций 543616.BO
54
Нет оценки
Количественный анализ Eyestock не покрывает акции Trident Lifeline Ltd.
Капитализация млрд. $
0.015
Дивидендная доходность
—
Оборот
11.5 млрд
Сайт компании
https://www.tridentlifeline.com/Trident Lifeline Ltd. manufactures and markets pharmaceutical products. The company is headquartered in Surat, Gujarat and currently employs 36 full-time employees. The company went IPO on 2022-10-10. The firm operates through seven geographical segments: India, Ghana, Kenya, Nigeria, Cameroon, Venezuela, Rest of World. The firm offers a range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. The company deals in capsules, tablets, liquid ointment, gel, ice gel, mouthwash, paste, solution, suspension, dry powders, and toothpaste. Its product portfolio includes a range of drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozoal, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, Non-Steroidal Anti-Inflammatory Drug (NSAIDS).